PDCD1 and neoplasm: The expression of CXCL13 seems to be not only predictive to ICB response when measured in baseline tumor tissue but is also associated with ICB outcome when evaluated in TIL exhibiting high expression of PD-1, in metastatic urothelial carcinoma and NSCLC, respectively [122,126].